UKRI – MRC Fostering translational clinical research via industry partnership
The Medical Research Council (MRC) has partnered with AstraZeneca to provide six MRC clinical fellows with one-year industry placement opportunities.
Partnering with academic clinicians is essential for any clinical trial research, and helps ensure that trials translate into current clinical practice and remain focused on the needs of patients.
However, in the UK, the number of academic clinicians within the health system is predicted to decline. This trend could make future clinical research more challenging.
As part of UKRI’s commitment to fostering translational clinical research in the UK, MRC is partnering with the AstraZeneca on one-year industry placement opportunities within their BioPharmaceuticals Research and Development (R&D) business.
Published on the 22nd of May 2024. Read the entire news here.
OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (4 novembre 2024). UKRI – MRC Fostering translational clinical research via industry partnership. ELSIBI. Consulté le 19 janvier 2025 à l’adresse https://doi.org/10.58079/12m6w